☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MTRAC review Cox-II NSAIDs

The Midlands Therapeutic Review and Advisory Committee (MTRAC) has reviewed the evidence for the three Cox-II NSAIDs.

They have issued review on:

The reviews covered 25 randomised controlled studies involving celecoxib, 13 involving etoricoxib and 8 involving lumiracoxib. All three reviews found that evidence of efficacy for these drugs was strong but concerns about cardiovascular safety gives this class of drugs a low place in therapy.

Action: These review provide a useful summary and reminder of the efficacy and safety evidence for Cox-II NSAIDs.

Share 'MTRAC review Cox-II NSAIDs' by emailShare 'MTRAC review Cox-II NSAIDs' on FacebookShare 'MTRAC review Cox-II NSAIDs' on TwitterShare 'MTRAC review Cox-II NSAIDs' on LinkedInShare 'MTRAC review Cox-II NSAIDs' on reddit


No Comments to “MTRAC review Cox-II NSAIDs”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.